about
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is current...
Read More
2.92
-0.12
(-3.95%)
5.1M
XNAS Volume
High vol.+loss this week
XNAS 03 Mar, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
Mannkind Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..